Activation of M(1) and M(4) muscarinic receptors as potential treatments for Alzheimer’s disease and schizophrenia

Alzheimer’s disease (AD) and schizophrenia (SZ) are neurological disorders with overlapping symptomatology, including both cognitive deficits and behavioral disturbances. Current clinical treatments for both disorders have limited efficacy accompanied by dose-limiting side effects, and ultimately fa...

Descripción completa

Detalles Bibliográficos
Autores principales: Foster, Daniel J, Choi, Derrick L, Conn, P Jeffrey, Rook, Jerri M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913542/
https://www.ncbi.nlm.nih.gov/pubmed/24511233
http://dx.doi.org/10.2147/NDT.S55104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913542/
https://www.ncbi.nlm.nih.gov/pubmed/24511233
http://dx.doi.org/10.2147/NDT.S55104

Ejemplares similares